Gyrolab® 2G Generic PK Kit
Gyros Protein TechnologiesThe Gyrolab® 2G Generic PK Kit enables high sensitivity quantitation of intact human IgG (IgG1, IgG2, IgG4 subtypes) in preclinical matrices
The Gyrolab® 2G Generic PK Kit enables high sensitivity quantitation of intact human IgG (IgG1, IgG2, IgG4 subtypes) in preclinical matrices
Abbott's AlinIQ Integrated Platform analyzes currently siloed datasets to help hospitals make more informed decisions based on their unique needs
Based on the results, the U.S.-based trial has been stopped, including in a second cohort of patients who received a higher dose of Kevzara (800 mg)